Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CLPro inhibitors. 2017

Vathan Kumar, and Jin Soo Shin, and Jiun-Jie Shie, and Keun Bon Ku, and Chonsaeng Kim, and Yun Young Go, and Kai-Fa Huang, and Meehyein Kim, and Po-Huang Liang
Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.

Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe acute respiratory illness with fever, cough and shortness of breath. Up to date, it has resulted in 1826 human infections, including 649 deaths. Analogous to picornavirus 3C protease (3Cpro), 3C-like protease (3CLpro) is critical for initiation of the MERS-CoV replication cycle and is thus regarded as a validated drug target. As presented here, our peptidomimetic inhibitors of enterovirus 3Cpro (6b, 6c and 6d) inhibited 3CLpro of MERS-CoV and severe acute respiratory syndrome coronavirus (SARS-CoV) with IC50 values ranging from 1.7 to 4.7 μM and from 0.2 to 0.7 μM, respectively. In MERS-CoV-infected cells, the inhibitors showed antiviral activity with EC50 values ranging from 0.6 to 1.4 μM, by downregulating the viral protein production in cells as well as reducing secretion of infectious viral particles into culture supernatants. They also suppressed other α- and β-CoVs from human and feline origin. These compounds exhibited good selectivity index (over 70 against MERS-CoV) and could lead to the development of broad-spectrum antiviral drugs against emerging CoVs and picornaviruses.

UI MeSH Term Description Entries
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D002415 Cats The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801) Felis catus,Felis domesticus,Domestic Cats,Felis domestica,Felis sylvestris catus,Cat,Cat, Domestic,Cats, Domestic,Domestic Cat
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014764 Viral Proteins Proteins found in any species of virus. Gene Products, Viral,Viral Gene Products,Viral Gene Proteins,Viral Protein,Protein, Viral,Proteins, Viral
D045473 Severe acute respiratory syndrome-related coronavirus A species of CORONAVIRUS causing atypical respiratory disease (SEVERE ACUTE RESPIRATORY SYNDROME) in humans. The organism is believed to have first emerged in Guangdong Province, China, in 2002. The natural host is the Chinese horseshoe bat, RHINOLOPHUS sinicus. HCoV-SARS,SARS Virus,SARS-Associated Coronavirus,SARS-CoV,SARS-CoV-1,SARS-like coronavirus,SARSr-CoV,SARSrCoV,Sarbecovirus,Severe Acute Respiratory Syndrome Virus,Severe acute respiratory syndrome coronavirus,SARS Coronavirus,SARS-Related Coronavirus,Urbani SARS-Associated Coronavirus,Coronavirus, SARS,Coronavirus, SARS-Associated,Coronavirus, SARS-Related,Coronavirus, Urbani SARS-Associated,SARS Associated Coronavirus,SARS Related Coronavirus,SARS like coronavirus,SARS-Associated Coronavirus, Urbani,SARS-like coronaviruses,SARSrCoVs,Sarbecoviruses,Severe acute respiratory syndrome related coronavirus,Urbani SARS Associated Coronavirus
D055808 Drug Discovery The process of finding chemicals for potential therapeutic use. Drug Prospecting,Discovery, Drug,Prospecting, Drug
D057786 Peptidomimetics Compounds that are designed to mimic the 3D structure of a natural peptide or protein. Peptidomimetic
D017934 Coronavirus A member of CORONAVIRIDAE which causes respiratory or gastrointestinal disease in a variety of vertebrates. Coronavirus, Rabbit,Coronaviruses,Rabbit Coronavirus,Coronaviruses, Rabbit,Rabbit Coronaviruses

Related Publications

Vathan Kumar, and Jin Soo Shin, and Jiun-Jie Shie, and Keun Bon Ku, and Chonsaeng Kim, and Yun Young Go, and Kai-Fa Huang, and Meehyein Kim, and Po-Huang Liang
September 2017, Disease-a-month : DM,
Vathan Kumar, and Jin Soo Shin, and Jiun-Jie Shie, and Keun Bon Ku, and Chonsaeng Kim, and Yun Young Go, and Kai-Fa Huang, and Meehyein Kim, and Po-Huang Liang
January 2017, British journal of hospital medicine (London, England : 2005),
Vathan Kumar, and Jin Soo Shin, and Jiun-Jie Shie, and Keun Bon Ku, and Chonsaeng Kim, and Yun Young Go, and Kai-Fa Huang, and Meehyein Kim, and Po-Huang Liang
December 2014, Virus research,
Vathan Kumar, and Jin Soo Shin, and Jiun-Jie Shie, and Keun Bon Ku, and Chonsaeng Kim, and Yun Young Go, and Kai-Fa Huang, and Meehyein Kim, and Po-Huang Liang
May 2020, Medecine et maladies infectieuses,
Vathan Kumar, and Jin Soo Shin, and Jiun-Jie Shie, and Keun Bon Ku, and Chonsaeng Kim, and Yun Young Go, and Kai-Fa Huang, and Meehyein Kim, and Po-Huang Liang
August 2013, Current infectious disease reports,
Vathan Kumar, and Jin Soo Shin, and Jiun-Jie Shie, and Keun Bon Ku, and Chonsaeng Kim, and Yun Young Go, and Kai-Fa Huang, and Meehyein Kim, and Po-Huang Liang
March 2019, Germs,
Vathan Kumar, and Jin Soo Shin, and Jiun-Jie Shie, and Keun Bon Ku, and Chonsaeng Kim, and Yun Young Go, and Kai-Fa Huang, and Meehyein Kim, and Po-Huang Liang
December 2014, Australian veterinary journal,
Vathan Kumar, and Jin Soo Shin, and Jiun-Jie Shie, and Keun Bon Ku, and Chonsaeng Kim, and Yun Young Go, and Kai-Fa Huang, and Meehyein Kim, and Po-Huang Liang
August 2013, Annals of the Academy of Medicine, Singapore,
Vathan Kumar, and Jin Soo Shin, and Jiun-Jie Shie, and Keun Bon Ku, and Chonsaeng Kim, and Yun Young Go, and Kai-Fa Huang, and Meehyein Kim, and Po-Huang Liang
July 2014, Archives of virology,
Vathan Kumar, and Jin Soo Shin, and Jiun-Jie Shie, and Keun Bon Ku, and Chonsaeng Kim, and Yun Young Go, and Kai-Fa Huang, and Meehyein Kim, and Po-Huang Liang
September 2020, Disease-a-month : DM,
Copied contents to your clipboard!